Update on Recently FDA Approved Belimumab for Lupus Nephritis: What Are the Response Rates and Toxicity Profile? What Are the Current Filgotinib Efficacy Updates for RA?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Update on Recently FDA Approved Belimumab for Lupus Nephritis: What Are the Response Rates and Toxicity Profile? What Are the Current Filgotinib Efficacy Updates for RA?

By RheumNow FEATURING John J. Cush

469 views

January 13, 2021

Comments 1

Are your patients with moderate to severe Rheumatoid Arthritis (RA) …

Feat. O. Troum, A. Wells, A. Broadwell, G. Wright

How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

23.5K views

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

7.4K views

Ever-Evolving Lupus Case & Cytopenias in SLE

Medical Specialty Institute

E. Littlejohn

199 views

Day 4 Recap: ACR Convergence 2024 Highlights

RheumNow

J. Pope, D. Liew, A. Sood

74 views

Methotrexate and the Gut Microbiome

RheumNow

R. Blank

102 views

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

Daniel Arkfeld

6.2K views

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

4.4K views

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

5.0K views

Thrombotic Risks in Lupus: Can We Predict Risk of Thrombosis in SLE?…

RheumNow

M. Petri

39 views

Update in the Understanding and Management of Lupus

ARTHROS

M. Petri

3.0K views

Health Disparities in SLE

Hospital for Special Surgery

J. Yazdany

160 views

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

3.2K views

Hurdles on the Way to Disease Modification in Lupus

ARTHROS

M. Petri

128 views

Lupus Medication Management Tips: How to Manage the Side Effects of …

The Lupus Foundation, Philadelphia Tri-State Chapter

A. Askanase

128 views

USSONAR Rheumatology Ultrasound Case Series: Rheumatoid Arthritis an…

USSONAR

J. Yinh

218 views

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

3.4K views

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

4.3K views

Systemic and Cutaneous Lupus Consideration

Masterclasses in Dermatology

J. Merola

210 views

SLE Faculty Panel: Q&A at RheumNow Live! 2024

RheumNow

D. Karp, J. Michelle Kahlenberg, A. Fava

140 views

AUTOPLAY

Login

Login

Join VuMedi

Update on Recently FDA Approved Belimumab for Lupus Nephritis: What Are the Response Rates and Toxicity Profile? What Are the Current Filgotinib Efficacy Updates for RA?

Are your patients with moderate to severe Rheumatoid Arthritis (RA) …

Related Videos

How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Vitamin D Deficiency

Ever-Evolving Lupus Case & Cytopenias in SLE

Day 4 Recap: ACR Convergence 2024 Highlights

Methotrexate and the Gut Microbiome

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

Interstitial Lung Disease in Rheumatic Diseases

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

Thrombotic Risks in Lupus: Can We Predict Risk of Thrombosis in SLE?…

Update in the Understanding and Management of Lupus

Health Disparities in SLE

Dermatologic Manifestations in Rheumatic Diseases

Hurdles on the Way to Disease Modification in Lupus

Top Shoulder Problems You See in the Office

Lupus Medication Management Tips: How to Manage the Side Effects of …

USSONAR Rheumatology Ultrasound Case Series: Rheumatoid Arthritis an…

2022 Updates on the Management of Lupus Nephritis

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

Systemic and Cutaneous Lupus Consideration

SLE Faculty Panel: Q&A at RheumNow Live! 2024